Image: Computational design of inhibitors for T. cruzi trans-sialidase

What we do

Richard Bryce

The research in the Bryce group is aimed at developing computational models to improve the accuracy with which molecular processes are described and understood in the condensed phase and then to integrate and employ these methods in the drug design and development process, involving collaboration with medicinal chemists, biochemists and biologists.